Home > Insider Trading > Filing (0001209191-23-027852)

Filing Details

Accession Number:: 0001209191-23-027852
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-08 07:03:54
Reporting Period:: 2023-05-05

Accepted Time:: 2023-05-08 07:03:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
944809	Opko Health Inc.	OPK	Pharmaceutical Preparations (2834)	752402409

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1867450	J. Gary Nabel	4400 Biscayne Blvd. Miami FL 33137	Chief Innovation Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-05	19,285	$1.78	94,756	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	3,185	$1.79	97,941	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	27,777	$1.80	125,718	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	27,624	$1.81	153,342	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	79,334	$1.82	232,676	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	19,475	$1.83	252,151	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	10,928	$1.83	263,079	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	28,538	$1.82	19,886,052	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2023-05-05	26,407	$1.85	19,912,459	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2023-05-05	54,945	$1.82	19,912,459	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2023-05-05	34,338	$1.84	114,338	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2023-05-05	54,346	$1.84	168,684	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2023-05-05	20,009	$1.85	188,693	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2023-05-05	54,054	$1.85	242,747	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.